Time course studies on the initiation of complement activation in acute myocardial infarction induced by coronary artery ligation in rats.
This study attempted to probe the role of complement activation in promoting acute myocardial infarction (AMI) induced by coronary artery ligation (CAL) in rats. The surgical technique used in this study significantly reduced early mortality (95% survival rate) and also reduced the variation in infarct size (33+/-1.87%) at 32 h after surgery. Time course studies on the initiation of AMI at various time points were carried out using physiological, biochemical, histopathological and electron microscopical techniques. Serum markers and activities of lysosomal hydrolases were found to be significantly elevated at the 8th hour post ligation. Histological studies showed polymorphonuclear cells emigration and total coagulation necrosis. Transmission electron micrograph exhibited mild distortion of muscle fibres and mitochondrial rupture with disrupted cristae. Immunoblotting studies confirmed the presence of alpha2-macroglobulin which supported the inflammatory response at 8th h of post ligation. The initiation of the complement (C) activation was observed by the increase in the level of the soluble form of the membrane attack complex (sC5b-9) in serum and left ventricle. Immunoexpression studies confirmed the initiation of the terminal C activation as shown by the expression of C5, C6, C7, C8, C9 and sC5b-9 complex at the 8th h of AMI. This study conclusively demonstrated that initiation of the C activation was observed to be significant at the 8th h of AMI induced by CAL in rats.
Sumitra
Miriyala
M
Department of Biotechnology, Central Leather Research Institute, Adyar, Chennai, India.
Manikandan
Panchatcharam
P
Nayeem
Mohammed
M
Manohar
Bhakthavatsalam Murali
BM
Lokanadam
Beema
B
Vairamuthu
Subbiah
S
Subramaniam
Samu
S
Puvanakrishnan
Rengarajulu
R
D000818:Animals; D003167:Complement Activation; D003165:Complement System Proteins / Q000032:analysis* / Q000378:metabolism; D006352:Heart Ventricles / Q000378:metabolism* / Q000473:pathology; D008297:Male; D009203:Myocardial Infarction / Q000097:blood* / Q000473:pathology; D009206:Myocardium / Q000378:metabolism* / Q000473:pathology; D051381:Rats; D017208:Rats, Wistar; D013997:Time Factors; D000511:alpha-Macroglobulins / Q000032:analysis / Q000378:metabolism
D000511:alpha-Macroglobulins; D003165:Complement System Proteins
Mol Cell Biochem. 2001 Aug;224(1-2):135-42
11693190
J Exp Med. 1969 Sep 1;130(3):505-18
4185247
Coron Artery Dis. 1994 Oct;5(10):865-72
7866607
Immunol Today. 1997 Mar;18(3):111-5
9078682
Am J Cardiol. 1972 Oct;30(5):492-7
5073661
Jpn Circ J. 1982 Dec;46(12):1337-44
7143702
Fed Proc. 1973 Apr;32(4):1489-93
4121833
Am Heart J. 1981 May;101(5):593-600
6164281
Clin Chim Acta. 2003 Mar;329(1-2):39-51
12589964
J Immunol. 1981 May;126(5):1820-5
7217669
Biochim Biophys Acta. 1973 Sep 21;322(1):62-7
4270367
Can J Cardiol. 1989 May;5(4):211-21
2567203
Ann N Y Acad Sci. 1994 Jun 17;723:1-14
8030857
Eur Heart J. 1994 Mar;15(3):418-23
8013522
J Endocrinol. 1999 Jul;162(1):143-53
10396031
Pharmacology. 2002 May;65(2):103-9
11937781
Am J Cardiol. 1977 Jul;40(1):110-29
327784
Biochim Biophys Acta. 1971 Aug 20;242(2):428-36
4258518
Circ Res. 1998 Oct 19;83(8):860-9
9776733
FASEB J. 1991 Aug;5(11):2529-37
1868978
J Clin Invest. 1977 May;59(5):911-21
853127
Pharmacol Res. 2000 Jun;41(6):613-27
10816330
Clin Cardiol. 1993 Feb;16(2):143-6
8435928
Int Immunopharmacol. 2001 Mar;1(3):403-14
11367525
J Biol Chem. 1951 Nov;193(1):265-75
14907713
Angiology. 1960 Oct;11:398-407
13749954
Am J Pathol. 1978 Jul;92(1):187-214
686146
Circulation. 1999 Jul 6;100(1):96-102
10393687
Circ Res. 1969 Jun;24(6):851-6
5786790
Biochem J. 1990 Jan 1;265(1):233-41
2154182